Photo by rawpixel.com on Pexels.com

What About the New 52-Week High Mark for a Stock?

What is the Most Profitable Approach to Trading New 52-Week High Stocks?

(By Glenford S. Robinson)

Well, any stock hitting a new 52-week high has performed exceptionally well during a one-year span. So, one would think that if a stock has performed well for the span of one year, traders or investors should buy the stock. Well, for the long-term investor that approach could be a profitable strategy. However, for the trader who is in the market to make a weekly living as a short-term trader, that strategy might not be such a wise one.

For the short-term minded trader who elects to buy the stock as a result of its 52-week outstanding performance, short-term trouble could be on the horizon. The main reason why there could be trouble is that professional and institutional traders use a stock’s 52-week high mark has a take-profit point where they lock in their gains accrued over the past year. Many professional and institutional traders give up further price-increase to lock in their gains although 52-week highs represent bullish sentiments.

In fact, stocks hitting new 52-week highs are most often than not profit-taking targets, resulting in massive down trend reversals after the 52-week mark has been reached. So, the most profitable short-term approach in trading stocks hitting new 52-week highs is shorting the hell out of the stock starting on the day the stock hit its 52-week high. Following such strategy will be proven very profitable when employed on a short-term basis. Don’t expect to short 52-week highs stock on a long-term basis because there was a valid fundamental reason why the stock’s price has performed well over the span of 52 weeks. So, if a dose of long-term shorting is employed, trading account destruction would be inevitable.

A short-term shorting approach is therefore the most logical approach to take in such instance with a dose of discipline sprinkled over the greed of long-term gains. Greed is never good. Fear is better because it puts profits in traders’ pockets when used wisely. The successful trader avoids greed and trades fear not succumbing to it. She trades fear by shorting greed to make a profit.

Trading fear will make you the most money as a trader, while succumbing to greed and fear will cause you to lose a lot of money as a trader.
A long-term strategy could be very profitable when trading 52-week high stocks if the long-term strategy is followed.

The 52-week high mark for a stock can either be used as an entry point or an exit point in trading the stock. It is for that reason why the 52-week high mark is such an important juncture in the price movement of a stock for traders.

Disclaimer: ©Mstardom, Inc. Mstardom Finance does not provide investment advice.

Source:

52-Week High/Low

A 52-week high/low is the highest and lowest price that a stock has traded at during the previous year. It is a technical indicator used by some traders and investors who view the 52-week high or low as an important factor in determining a stock’s current value and predicting future price movement.

Check Also

Alert image

Investor Alerts and Bulletins: The Escheatment Process

Keep your contact information updated. Financial institutions must attempt to notify you before escheating your account. Make sure financial institutions at which you have accounts have your accurate contact information (telephone, e-mail and physical address) to help ensure you receive any notices related to your accounts. If your financial institution sends you mail that is returned as undeliverable, or it cannot reach you through your other contact information, your account may be declared abandoned and end up in escheatment.

Where can I get business financing?

Horizon Technology Finance Provides Investment Portfolio Update Increases Portfolio Size with $24 Million in Loan Originations; Grows Committed Backlog to $47 Million

"During the third quarter, we experienced solid investment activity, increasing the size of our portfolio and expanding our committed backlog for the second consecutive quarter," said Gerald A. Michaud, President of Horizon. "Our success funding seven loans, totaling more than $24 million, and growing our committed backlog to $47 million underscores the strong demand for our venture debt products to growing life science and technology companies. We believe Horizon will continue to benefit from a robust pipeline of investment opportunities and is well positioned to deliver long-term, disciplined portfolio growth, while ensuring credit quality remains strong."

ECB profit increased in 2018

Financial Statements of the ECB for 2018

The ECB’s net profit is distributed to the euro area national central banks (NCBs). The Governing Council decided to make an interim profit distribution, amounting to €1,191 million, to the euro area NCBs on 31 January 2019. At yesterday’s meeting, the Governing Council decided to distribute the remainder of the profit, amounting to €384 million, on 22 February 2019.

Litigation Photo

Immune Design (IMDZ) Alert: Johnson Fistel Investigates Proposed Sale of Immune Design Corp.; Are Immune Design Shareholders Getting a Fair Deal?

The investigation concerns whether the Immune Design board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Immune Design shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given that one Wall Street analyst has a $9.00 price target on the stock and the Company has approximately $100 million in cash and no long-term debt.

Mergers and Acquisitions

Merck to Acquire Immune Design; Acquisition Bolsters Capabilities in Vaccine Development for Infectious Diseases and Cancer

“Scientists at Immune Design have established a unique portfolio of approaches to cancer immunization and adjuvant systems designed to enhance the ability of a vaccine to protect against infection, which could meaningfully improve vaccine development," said Dr. Roger M. Perlmutter, president, Merck Research Laboratories. “This acquisition builds upon Merck’s industry-leading programs that harness the power of the immune system to prevent and treat disease.”

SEC Files Charges in Elaborate Microcap Stock Fraud

“As alleged in our complaint, Magna Group and its co-defendants used fake debt instruments to unlawfully obtain shares in microcap companies, which they then dumped on unsuspecting retail investors,” said Sanjay Wadhwa, Senior Associate Director of the SEC’s New York Regional Office. “This action demonstrates the resolve of the SEC in pursuing fraudsters who use elaborate financing schemes to engage in securities fraud.”

Investor Alert and Bulletin From SEC Office of Investor Education and Advocacy

Know how to be a better investor. Did you know that active trading and some other very common investing behaviors actually can undermine investment performance? According to researchers, other common investing mistakes include focusing on past performance, favoring investments from your own country, region, state, or company, and holding on to losing investments too long and selling winning investments too soon.

%d bloggers like this: